Please enable JavaScript.
Coggle requires JavaScript to display documents.
Treatment and Prophylaxis of Bacterial Infections (CLINICAL USE OF…
Treatment and Prophylaxis
of Bacterial Infections
CLINICAL USE OF ANTIBACTERIAL AGENTS
■BETA-LACTAMS
Monobactams
Carbapenems
Adverse Reactions to a-Lactam Drugs
Cephalosporins
Penicillins and beta-Lactamase Inhibitors
■GLYCOPEPTIDES AND LIPOGLYCOPEPTIDES
■LIPOPEPTIDES
■AMINOGLYCOSIDES
■MACROLIDES AND KETOLIDES
■CLINDAMYCIN
■TETRACYCLINES AND GLYCYLCYCLINES
■TRIMETHOPRIM-SULFAMETHOXAZOLE
■FLUOROQUINOLONES
■RIFAMYCINS
■METRONIDAZOLE
■OXAZOLIDINONES
■NITROFURANTOIN
■QUINUPRISTIN-DALFOPRISTIN
■FOSFOMYCIN
■CHLORAMPHENICOL
ANTIMICROBIAL STEWARDSHIP
PHARMACOKINETICS AND
PHARMACODYNAMICS
■■PHARMACOKINETICS
Distribution
Metabolism
Excretion
Absorption
■■PHARMACODYNAMICS
APPROACH TO THERAPY
■■EMPIRICAL AND DIRECTED THERAPY
■■SITE OF INFECTION
■■HOST FACTORS
Pregnancy
Allergies
Drug–Drug Interactions
Exposures
Immune Dysfunction
■■EXPERT GUIDANCE
APPROACH TO PROPHYLAXIS OF INFECTION
MECHANISMS OF ACTION
■■INHIBITION OF BACTERIAL METABOLISM
Sulfonamides
Trimethoprim
■■INHIBITION OF DNA AND RNA SYNTHESIS OR
ACTIVITY
Quinolones
Rifamycins
Nitrofurantoin
Metronidazole
■■INHIBITION OF PROTEIN SYNTHESIS
Aminoglycosides
Tetracyclines and Glycylcyclines
Macrolides and Ketolides
Lincosamides
Streptogramins
Chloramphenicol
Oxazolidinones
Mupirocin
■■DISRUPTION OF MEMBRANE INTEGRITY
Polymyxins
Daptomycin
■■INHIBITION OF CELL WALL SYNTHESIS
Glycopeptides and Lipoglycopeptides
Bacitracin (Topical) and Fosfomycin
beta-Lactams